Pharmafile Logo
Pharmafocus logo
Advanced Search

Novo Nordisk

Showing 15 posts of 180 posts found.

Novo Nordisk HQ

Victoza superiority to Januvia made official by FDA

April 10, 2012
Medical Communications, Sales and Marketing Januvia, Merck, Novo Nordisk, Victoza, diabetes

Novo Nordisk is now able to claim superiority for its diabetes drug Victoza compared to Merck’s rival treatment Januvia.The US …

News
Novo Nordisk image

Diabetes – the battle for control

February 15, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Novo Nordisk, Sanofi, Victoza, degludec, diabetes

This year marks the 90th anniversary of the first ever successful use of insulin to treat patients with type I …

Feature

Study supports GLP-1 agonists for weight loss

January 10, 2012
Research and Development, Sales and Marketing GLP-1, Novo Nordisk, Sanofi, diabetes, lilly

An independent study by academics has concluded that GLP-1 agonist drugs help patients to lose weight – with the effect …

News

AstraZeneca, Novo and Enlight sign collaborative research deal

December 20, 2011
Research and Development, Sales and Marketing AstraZeneca, Enlight, Novo Nordisk

AstraZeneca and Novo Nordisk have linked up with a US biosciences firm in a bid to enhance their R&D operations. …

News

Novo confident on ultra-long acting insulin

December 8, 2011
Sales and Marketing Novo Nordisk, diabetes, insulin

Novo Nordisk says a new combination of a long-acting insulin with a short-acting insulin helps patients maintain better control of …

News
MediKidz' haemophilia comic

Novo Nordisk sponsors haemophilia comic

October 7, 2011
Medical Communications Novo Nordisk, haemophilia, medical communications news

Novo Nordisk is sponsoring an educational comic about haemophilia for young sufferers of the blood disorder in the UK. It …

News

Fresh scrutiny for new diabetes drugs

September 15, 2011
Sales and Marketing Byetta, GLP-1, Januvia, Merck, Novo Nordisk, Victoza, diabetes

Merck’s Januvia and Lilly’s Byetta face renewed safety questions this week as the European Association for the Study of Diabetes …

News
Novo Nordisk's Victoza (liraglutide)

Victoza data shows promise for early setting

September 13, 2011
Research and Development, Sales and Marketing Novo Nordisk, Victoza

New data for Novo Nordisk’s Victoza could help the drug’s chances of being used in an earlier setting for type …

News
Novo Nordisk

Novo Nordisk invests €134m in Danish facility

June 24, 2011
Manufacturing and Production Novo Nordisk, biologics, pharma manufacturing news

Novo Nordisk plans to invest almost 1 billion Danish kroner (134 million euros) in a new biologics manufacturing facility at …

News
Novo Nordisk headquarters

New product can overtake Lantus, says Novo leader

May 11, 2011
Sales and Marketing Novo Nordisk, degludec, diabetes, insulin

Novo Nordisk’s new insulin product can eclipse Sanofi’s Lantus within just a few years of its launch, according to Novo’s …

News
Novo Nordisk's type II diabetes drug Victoza (liraglutide)

Novo’s diabetes drug Victoza approved in China

March 16, 2011
Sales and Marketing Glucagon-Like Peptide-1, Novo Nordisk, Victoza, diabetes in China, liraglutide, type 2 diabetes

Novo Nordisk’s injectable diabetes drug Victoza has been given regulatory approval in China. The Chinese State Food and Drug Administration …

News
Diabetes injection

Pharma-NHS diabetes project begins

February 9, 2011
Sales and Marketing AstraZeneca, Lilly UK, MSD, NHS, Nottingham, Novartis, Novo Nordisk, Pfizer, Sanofi-Aventis, joint working

A joint venture between the NHS, charities and the pharma sector has begun in Nottingham to help treat the city’s …

News
Novo Nordisk's Victoza

Diabetes drugs show promise in Alzheimer’s

January 17, 2011
Research and Development Alzheimer's, Alzheimer’s, Byetta, Novo Nordisk, Victoza, diabetes, exenatide, lilly, liraglutide

Research suggests that new diabetes drugs enhance cell growth in the brain, and could help treat Alzheimer’s disease. Researchers at …

News

GSK’s Dr Anne Phillips moves to Novo Nordisk

January 4, 2011
Research and Development, Sales and Marketing Dr Anne Phillips, Novo Nordisk, apppointment, research and development, sales and marketing

Novo Nordisk has appointed Dr Anne Phillips as vice president for clinical, medical and regulatory affairs for North America. She …

Appointment

Novo to develop oral insulin

December 22, 2010
Research and Development Emisphere, Novo Nordisk, diabetes, insulin, oral insulin, type I diabetes

Novo Nordisk is to develop an oral formulation of insulin with US biotech company Emisphere Technologies. The New Jersey-based biotech …

News

Latest content

Eisai and Biogen’s Leqembi launched for Alzheimer’s treatment in China

June 28, 2024

AbbVie’s Tepkinly gains positive CHMP opinion for follicular lymphoma treatment

June 28, 2024

IDEAYA Biosciences announces first-patient-in for phase 1 clinical trial evaluating IDE397 and Trodelvy combination in MTAP-deletion bladder cancer

June 27, 2024

Immunotherapy created at Roswell Park Comprehensive Cancer Center given expanded ODD by FDA

June 27, 2024

Abcuro completes enrolment for phase 2/3 IBM treatment trial

June 26, 2024